All things data. One authority.
Life sciences · Brief

Cardiologists invent patients so heart notes can be shared

Doctors wrote artificial hospital reports in seven languages, so AI can learn from clinical notes with no real patient behind them.

10 November 2026 · 1 min read

A stack of blank hospital folders tied with string on a wooden desk beside a single penA stack of blank hospital folders tied with string on a wooden desk beside a single penA stack of blank hospital folders tied with string on a wooden desk beside a single pen

Picture made for ABUREAU.

Real patient notes are the data health AI most needs and the hardest to share. A European team found a way round it: write the patients. Cardiologists from seven hospitals wrote CliTe, 699 artificial cardiology reports in seven languages, covering outpatient, discharge and inpatient notes.

The reports cover ischaemic heart disease, heart failure and valvular disease. A second set, ParaCliTe, holds reports from 94 fictitious patients, each in all seven languages with sentence-level alignment, 658 documents in total. A third part is machine-translated and labelled as such.

The authors say the sets are meant for building AI tools in cardiology across languages. The paper page does not state a licence for the sets themselves or give a download link, so anyone planning to use them should check the supplement first.

For people who own or use data, this shows a middle path between locking records away and sharing them. Expert-written, fictional records carry clinical skill without carrying a patient. The open question is how closely they match real notes, and that is what buyers will want measured.

Find out what your data could be worth

Tell us what kinds of data your company holds. Buyers set the price, and you keep the data.

Start on abura.io
Sources

How these stories are written: each is drafted with AI from its primary source (the paper, filing, ruling or announcement itself), which the story links, and every figure links to where it came from. Each is held before publishing so our editor can stop it, and a story that names a person, accuses anyone, or covers a court case or a regulator's action goes live only when the editor says so. Other outlets' reporting is linked, never rewritten.

Get the weekly issue

One email a week once the issue starts, only the desks you pick. Leave whenever you like.

Your desks
Or follow topics
Your topics

We use your email only to send the issue. Your rights.

More from Life sciences

The data desks

Value
Protect
Share
Grow

Desks marked ↗ lead to related partner sites.